Skip to main content

EDIT- Editas Medicine, Inc.

Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO269.1K$796.5K-
VP62.4K$184.6K-4,928
CFO15.9K$47.1K-

Activity

Buys and sells only

Transactions

10 filings · page 4
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Sep 6, 2023Eaton Bruce80EVP, Cbo And CTOSell103$8.82$908.46-0.1%+20.4%-61.7%
Aug 11, 2023Eaton Bruce80EVP, Cbo And CTOSell702$8.59$6,032.64-0.9%-9.3%-54.3%
Aug 8, 2023Eaton Bruce80EVP, Cbo And CTOSell141$8.39$1,182.99-0.2%-6.6%-53.8%
Jul 19, 2023Mei Baisong77SVP, Chief Medical OfficerSell4,317$8.80$37,989.60-5.7%-22.8%-39.9%
Jun 5, 2023O'Neill Gilmore Neil69CEOSell6,486$9.50$61,637.76-4.7%-6.5%-39.1%
Jun 5, 2023Eaton Bruce80EVP, Cbo And CTOSell105$9.50$997.82-0.1%-6.5%-39.1%
May 11, 2023Robertson Michelle75EVP, Chief Financial OfficerSell949$9.87$9,368.53-0.9%-7.5%-44.4%
May 11, 2023Eaton Bruce80EVP, Cbo And CTOSell668$9.87$6,594.50-0.9%-7.5%-44.4%
May 9, 2023Eaton Bruce80EVP, Cbo And CTOSell135$9.51$1,283.85-0.2%-18.0%-51.0%
Mar 3, 2023Robertson Michelle75EVP, Chief Financial OfficerSell184$8.89$1,635.76-0.2%+6.6%+17.5%